Bluelinx Holdings Inc (BXC) |
|
|
|
EARNINGS REPORT by CSIMarket
Income Positive Again, but on the slower pace
Bluelinx Holdings Inc announced fourth quarter 2020 operating profit of $32.407 millions
![Supercenter_Theonlysilentbob_at_en.wikipedia__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Supercenter_Theonlysilentbob_at_en.wikipedia__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common](../news/../news/img/shopping/Supercenter_Theonlysilentbob_at_en.wikipedia__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common.jpg) Due to strong revenue growth company turned into profitability, Sales grew by 25.07 % to $ 849 millions, earnings per share were at $2.77, compare to $ -0.75 in the same quarter a year ago. Sequentially profit plummeted by -51.6 % from $5.72 per share and Sales decreased by -2.55 % from $871 millions. Company achieved net income of $26.114 millions in the fourth quarter 2020 an improvement versus a net loss of $ -7.043 millions in the same quarter a year ago. Bluelinx Holdings Inc also emphasized it's improving profit margins, where net margin rose to 3.08% in fourth quarter 2020, and operating margin edged up to 3.82%. Bluelinx Holdings Inc reported earnings of $ 81 millions and Sales of $ 3.10 billions for the fiscal year 2020. Company reported earnings per share of $8.55 compare to $-1.89 in the previous fiscal year, while Sales improved by 17.44 % from $2.64 billions a year ago. Bluelinx Holdings Inc is expected to report next financial results on March 02, 2022.
|
Recently Reported Results |
Cytodyn inc
Due to strong revenue growth company turned into profitability, Sales grew by 25.07 % to $849 millions, earnings per share were at $2.77, compare to $-0.75 in the same quarter a year ago.
Cytodyn Inc reported operating loss of $-30.785 millions, in the financial period ending Feb 28 2021, a deterioration from the operating shortfall of $-22.074684 millions, realized in third quarter of 2020
CYDY stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Producer Price Index
U.S. Producer price index continued to rise in February, but on the lower pace.
|
Enertopia Corp
Enertopia Corp announced operating loss of $-0.327792 millions, in the second quarter of 2021, a change from the operating shortfall of $-0.055649 millions, recorded in the same quarter a year ago.
ENRT stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Nanovation Microtech Inc
In the most recent fiscal period Nanovation Microtech Inc loss increased of $-0.12 per share compared to $0.00 a year ago and improved from $-0.38 per share from the previous quarter.
Nanovation Microtech Inc reported operating shortfall of $-0.00423 millions, in the most recent fiscal period, an improvement from the operating shortfall of $-0.055649 millions, realized in second quarter of 2020
NANN stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Cannabics Pharmaceuticals Inc
In the second quarter of 2021 Cannabics Pharmaceuticals Inc reached break-even of $0.00 per share compared to $-0.00 a year ago and from $-0.01 per share from the previous quarter.
Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.
CNBK stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Housing Starts
The construction of new homes, as well as the issuance of new building permits declined in February, signaling slowdown in economic growth and decrease in business profitability.
|
Durable Goods Orders
Durable Goods orders continued to grow, as bookings outgrow production.
|
Factory Orders
Factory orders continued to grow, as bookings outgrow production.
|
Citi Trends inc
Company displayed pleasant results in the fiscal fourth quarter of 2020. Sales were at $251.92 millions higher by 19.39% year on year and improved by 26.53 % quarter on quarter, while earnings per share more than doubled by 114.78 % to $1.80, sequentially eps more than doubled by 169.28 %.
In the fiscal year 2020, Citi Trends Inc reported Sales of $783.29 millions and net income of $23.98 millions. Eps soared by 64.54 % to $2.32 per share from $1.41 in the previous fiscal year, while Sales increased by 0.18 % from $781.93 millions a year ago.
CTRN stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Teardroppers Inc
Teardroppers Inc announced earnings per share of $-0.00 and Sales of $0.02 millions in the fourth quarter of 2020, Company's reached break-even per share, versus $-0.00 eps, earned in the same quarter a year ago, although Teardroppers Inc saw its Sales rise by 50.85% in the same period.
In contrast to the third quarter Sales increased by 3.89 % from $0.02 millions and from $0.00 per share. In the fiscal year 2020, Citi Trends Inc reported Sales of $783.29 millions and net income of $23.98 millions. Eps soared by 64.54 % to $2.32 per share from $1.41 in the previous fiscal year, while Sales increased by 0.18 % from $781.93 millions a year ago.
TRDP stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Genethera Inc
In the fourth quarter of 2020 earnings season Genethera Inc reached break-even of $-0.00 per share compared to $-0.01 a year ago and from $-0.01 per share from the previous quarter.
Genethera Inc reported operating loss of $-0.132123 millions, in the fourth quarter of 2020 earnings season, an improvement from the operating shortfall of $-0.239101 millions, realized in fourth quarter of 2019 Genethera Inc reported net loss of $-0.77 millions and Sales of $0.00 millions for the fiscal year 2020. Net loss per share has widen to $-0.04 from $-0.01 in previous fiscal year, while by 0 % from $0.00 millions a year ago.
GTHR stock quotes, charts, profile
Growth Rates, Profitability, PE
|
High Sierra Technologies Inc
In the fiscal period ending Dec 31 2020 High Sierra Technologies Inc increased losses of $-0.01 per share compared to $-0.00 a year ago and from $0.00 per share from the previous quarter.
High Sierra Technologies Inc reported operating shortfall of $-0.187955 millions, in the fiscal period ending Dec 31 2020, a deterioration from the operating income of $0.012858 millions, realized in fourth quarter of 2019 Genethera Inc reported net loss of $-0.77 millions and Sales of $0.00 millions for the fiscal year 2020. Net loss per share has widen to $-0.04 from $-0.01 in previous fiscal year, while by 0 % from $0.00 millions a year ago.
GLFO stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Eaco Corp
Eaco Corp realized a deterioration in earnings per share by -47.17% to $0.28 and Sales decrease by -1.9% to $55.75 millions in the fiscal time frame ending Feb 28 2021, year on year.
From the preceding quarter, eps soared from $0.17 per share and Sales increased by 4.4 % from $53.40 millions.
EACO stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Cannapharmarx Inc
Company reports $-11.55 million loss, as impairment charges strip off $6.03 million from the fourth quarter of 2020 results.
Cannapharmarx Inc reported operating loss of $-9.815889 millions, in the fourth quarter of 2020, a deterioration from the operating shortfall of $-7.985159 millions, realized in fourth quarter of 2019 Cannapharmarx Inc reported net loss of $-19.89 millions and Sales of $0.00 millions for the fiscal year 2020. Company has decreased loss per share to $-0.49 from $-0.66 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.
CPMD stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
|
|
|
|
|